News and Highlights RSS
Notices of Intent for Alliance Funding Opportunities
The Office of Cancer Nanotechnology Research has issued notices of intent to publish funding opportunities to support cancer nanotechnology research as part of the NCI Alliance for Nanotechnology in Cancer. The announcements will be published in Spring/Summer 2014, with the first estimated application due dates in Fall 2014.
- Centers of Cancer Nanotechnology Excellence (U54)
- Cancer Nanotechnology Research Platforms (U01)
- Nanotechnology Research Training Programs
NCI Requests Cancer Targets for Monoclonal Antibody Production and Characterization
In an effort to provide well–characterized monoclonal antibodies to the scientific community, NCI's Antibody Characterization Program requests cancer–related protein targets for affinity production and distribution.
The program from The Office of Cancer Clinical Proteomics Research provides reagents and other critical resources that support protein/peptide measurements and analysis. Requests will be reviewed and considered for merit based on their justification and contribution to existing NCI–funded projects. Priority will be given to projects applying the antibodies to proteomics research.
Submissions will be accepted through July 11, 2014.
For more information and the application form, please go to NCI's Antibody Data Portal at antibodies.cancer.gov.
NCI caNanoLab Nanomaterial Data Repository Survey
The National Cancer Institute Office of Cancer Nanotechnology Research is working together with the NCI Center for Biomedical Informatics and Information Technology to submit nanotechnology data to the caNanoLab data repository.
The objective is to curate cancer nanotechnology data under defined conditions in order to expedite the use of these data in the development of novel agents for cancer diagnostics and therapeutics. In order to do this, a survey is being conducted to learn what data sources are most relevant to you and to identify gaps in the caNanoLab database.